VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 137 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $554,000 | +18.9% | 33,794 | -3.7% | 0.02% | -32.0% |
| Q3 2019 | $466,000 | -11.4% | 35,097 | -6.0% | 0.02% | +25.0% |
| Q2 2019 | $526,000 | -22.4% | 37,350 | +1.3% | 0.02% | -48.7% |
| Q1 2019 | $678,000 | +189.7% | 36,854 | +199.6% | 0.04% | +680.0% |
| Q2 2018 | $234,000 | -41.8% | 12,300 | -48.5% | 0.01% | -28.6% |
| Q1 2018 | $402,000 | -84.6% | 23,900 | -83.7% | 0.01% | -76.7% |
| Q3 2017 | $2,616,000 | +245.6% | 146,200 | +214.4% | 0.03% | +172.7% |
| Q2 2017 | $757,000 | +177.3% | 46,500 | +90.6% | 0.01% | -15.4% |
| Q2 2016 | $273,000 | +129.4% | 24,400 | +70.6% | 0.01% | +116.7% |
| Q1 2016 | $119,000 | -70.2% | 14,300 | -59.6% | 0.01% | -80.0% |
| Q3 2015 | $399,000 | +44.6% | 35,400 | +62.4% | 0.03% | -28.6% |
| Q2 2015 | $276,000 | -61.7% | 21,800 | -50.9% | 0.04% | +23.5% |
| Q1 2014 | $721,000 | – | 44,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |